Position
SYNTAX RESEARCH, INC. in Amgen Inc
Back to the book · All holders of AMGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $5.82K$327.31 → $351.85
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 237 | $77.6K | — | — | — | 0.0% |
| Q1 2026 | 237 | $83.4K | $351.85 | $5.82K | −$0 | 0.1% |